期刊文献+

乙型肝炎病毒表面抗原检测敏感度和标准化问题

Deficiencies in the Standardization and Sensitivity of Detection for Hepatitis B Virus Surface Antigen
下载PDF
导出
摘要 乙型肝炎病毒(HBV)感染是一个全球性公共卫生问题。HBV表面抗原(HBsAg)是目前诊断急性和慢性HBV感染的最重要血清学标志物。但是HBsAg阴性并非意味着没有HBV感染,检测误差主要由病毒、宿主或者检测试剂盒造成。提高检测方法的敏感度有助于降低满检率,建立标准化检测可以发挥HBsAg定量检测在临床中的价值。同时结合HBVDNA和HBV核心抗体(HBcAb)可以提高HBV感染的检测率,保障临床输血和器官移植安全。 Hepatitis B virus (HBV) infection is a global public health problem. HBV surface antigen (HBsAg) is considered as a most important serum markers of diagnostic test for acute or chronic HBV infection. However,negative for HBsAg is not equal to being away from HBV infection. The reasons on deficiencies of detection are complex, such as virus itself, host or assay kit. It is important to elevate the sensitivity of detection in order to decrease the omission rate. Meanwhile, if we want to take advantage of the HBsAg quantitation in chnical, we should establish the standardized detection. In addition, HBsAg com- bined with HBV DNA and HBV core antibody, may increase the accuracy of detection on HBV infection, as well as ensure the safety of clinical transfusion and organ transplantation.
出处 《医学综述》 2009年第12期1884-1885,共2页 Medical Recapitulate
关键词 乙型肝炎病毒 表面抗原 逃逸突变 核心抗体 HBV DNA 敏感度 标准化 Hepatitis B virus Surface antigen Escape mutant Core antibody HBV DNA Sensitivity Standardization
  • 相关文献

参考文献12

  • 1Togashi H,Hashimoto C,Yokozawa J,et al.What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?[J].J Hepatol,2008,49(1):17-24.
  • 2Gerlich WH,Glebe D.Schmtler CG.Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus[J].J Viral Hepat,2007,14(Suppl 1):16-21.
  • 3Erhardt A,Reineke U,Blondin D,et al.Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B[J].Hepatology,2000,31(3):716-725.
  • 4Chulanov VP,Shipulin GA,Schaefer S,et al.Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses[J].J Med Virol,2003,69 (3):313-323.
  • 5Kleinman SH,Busch MP.Assessing the impact of HBV NAT on window period reduction and residual risk[J].J Clin Virol,2006,36(Suppl 1):S23-S29.
  • 6Minegishi K,Yoshikawa A,Kishimoto S,et al.Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening[J].Vox Sang,2003,84(4):287-291.
  • 7Lin CL,Kao JH.Hepatitis B viral factors and clinical outcomes of chronic hepatitis B[J].J Biomed Sci,2008,15(2):137-145.
  • 8Levicnik-Stezinar S.Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening as say[J].Clin Lab,2004,50(1/2):49-51.
  • 9Boni C,Fisicaro P,Valdatta C,et al.Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infec tion[J].J Virol,2007,81(8):4215-4225.
  • 10Kupski C,Trasel FR,Mazzoleni F,et al.Serologic and molecular profile of anti-HBc-positive blood bank donors in an area of low en demicity for HBV[J].Dig Dis Sci,2008,53(5):1370-1374.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部